Page 115 - 《中国药房》2023年12期
P. 115

·药师与药学服务·


          药师参与多学科诊疗的模式探讨及效果评价
                                                                              Δ

                                                    1, 3 #
          李 赟    1, 2* ,王立新 ,郭 阳 ,田 杰 ,刘 芳 (1.北京大学第三医院药剂科,北京 100191;2.山西医科大
                                            2
                                    2
                            2
          学第一医院药学部,太原 030001;3.北京大学医学部药品评价中心,北京 100191)
          中图分类号  R95      文献标志码  A      文章编号  1001-0408(2023)12-1515-05
          DOI  10.6039/j.issn.1001-0408.2023.12.20

          摘  要  目的  评价药师参与多学科诊疗(MDT)的模式及效果。方法  计算机检索Cochrane图书馆、PubMed、Embase、中国知网、
          中国生物医学文献数据库和万方数据,收集药师参与MDT对患者临床结局影响的试验性研究和观察性研究。提取资料和评价质
          量后,对纳入研究的结果进行描述性分析。结果  共纳入10项研究,其中3项研究为随机对照试验(RCT),2项研究为非RCT,4项
          研究为队列研究,1项研究为病例对照研究;共计2 422例患者。有效性方面,药师参与MDT后患者的肿瘤无进展生存期、糖化血
          红蛋白、再入院率和住院时间等指标均显著改善。安全性方面,药师参与MDT后患者大出血事件发生率显著降低。经济性方面,
          药师参与MDT后患者与药物相关的住院费用、平均门诊医疗费用总额均显著改善,但医疗费用未见明显改善。人文结局方面,药
          师参与MDT后患者的依从性结论存在争议。结论  药师根据自身的药学服务技能和方法,全程化地参与MDT,改善了患者的临
          床结局,提高了用药的安全性,但在经济性和人文结局方面尚存在争议。
          关键词  药师;多学科诊疗;系统评价;参与模式;效果

          Investigation  of  the  mode  of  pharmacist  participating  in  multi-disciplinary  diagnosis  and  treatment  and
          effect evaluation
          LI Yun ,WANG Lixin ,GUO Yang ,TIAN Jie ,LIU Fang (1.  Dept.  of  Pharmacy,  the  Third  Hospital  of
                                           2
                                                     2
                1, 2
                               2
                                                                1, 3
          Peking  University,  Beijing  100191,  China;2.  Dept.  of  Pharmacy,  the  First  Hospital  of  Shanxi  Medical
          University,  Taiyuan  030001,  China;3.  Drug  Evaluation  Center,  Peking  University  Health  Science  Center,
          Beijing 100191, China)
          ABSTRACT   OBJECTIVE  To  evaluate  the  mode  of  pharmacists’  participation  in  multi-disciplinary  diagnosis  and  treatment
         (MDT),  as  well  as  the  effects  of  pharmacists’  participation.  METHODS  Retrieved  from  Cochrane  Library,  PubMed,  Embase,
          CNKI,  CBM  and  Wanfang  database,  experimental  studies  and  observational  studies  on  the  effects  of  MDT  with  pharmacists  on
          clinical  outcomes  of  patients  were  collected.  After  data  extraction  and  quality  evaluation,  the  results  of  included  studies  were
          analyzed descriptively. RESULTS A total of 10 studies were included, among which 3 were randomized controlled trials (RCT), 2
          were  non-RCT,  4  were  cohort  and  1  was  case-control  study;  there  were  2  422  patients  in  total.  In  terms  of  effectiveness,  tumor
          progression-free  survival,  glycosylated  hemoglobin,  re-admission  rate  and  length  of  stay  and  other  indexes  were  all  improved
          significantly  after  pharmacists  participated  in  MDT.  In  terms  of  safety,  the  incidence  of  major  bleeding  events  was  significantly
          decreased  after  pharmacists  participated  in  MDT.  In  terms  of  economy,  hospitalization  costs  and  total  outpatient  expenses  were
          improved  significantly  after  pharmacists  participated  in  MDT,  but  medical  cost  was  not  improved  significantly.  In  terms  of
          humanistic  outcomes,  there  was  controversy  over  the  conclusion  of  patient  compliance  after  pharmacists  participated  in  MDT.
          CONCLUSIONS Pharmacists, based on their own pharmaceutical care skills and methods, actively participate in MDT throughout
          the  process,  improving  the  clinical  outcomes  of  patients  and  enhancing  the  safety  of  medication.  There  are  still  controversies
          regarding economic and humanistic outcomes.
          KEYWORDS    pharmacist; multi-disciplinary treatment; systematic review; participation mode; effectiveness



             Δ 基金项目 首都卫生发展科研专项项目(No.首发2020-1-2031)               多学科诊疗(multi-disciplinary treatment,MDT)是
             *第一作者 副主任药师,硕士。研究方向:临床药学、医院药学。                  指由多学科专家针对某一种或某一系统疾病的患者进
          E-mail:103734502@qq.com
                                                             行讨论,在综合各学科意见的基础上为患者制定最佳治
             # 通信作者 主任药师,硕士。研究方向:临床药学、循证药学。电
          话:010-82266682。E-mail:liufang8-111@163.com         疗方案的治疗模式        [1—2] 。不同的MDT可根据团队成员的


          中国药房  2023年第34卷第12期                                              China Pharmacy  2023 Vol. 34  No. 12    · 1515 ·
   110   111   112   113   114   115   116   117   118   119   120